Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer: the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)

Saved in:

Bibliographic Details
Main Authors:	Minckwitz, Gunter von (Author) , Rezai, Mahdi (Author) , Tesch, Hans (Author) , Huober, Jens (Author) , Gerber, Bernd (Author) , Zahm, Dirk M. (Author) , Hilfrich, Jörn (Author) , Costa, Serban Dan (Author) , Dubsky, Peter (Author) , Blohmer, Jens-Uwe (Author) , Denkert, Carsten (Author) , Hanusch, Claus Alexander (Author) , Jackisch, Christian (Author) , Kümmel, Sherko (Author) , Fasching, Peter Andreas (Author) , Schneeweiss, Andreas (Author) , Paepke, Stefan (Author) , Untch, Michael (Author) , Burchardi, Nicole Diana (Author)
Format:	Article (Journal)
Language:	English
Published:	2016
In:	The European journal of cancer Year: 2016, Volume: 64, Pages: 12-21
ISSN:	0959-8049
Online Access:
Author Notes:	G. von Minckwitz, M. Rezai, H. Tesch, J. Huober, B. Gerber, D.M. Zahm, J. Hilfrich, S.D. Costa, P. Dubsky, J.U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, S. Kümmel, P.A. Fasching, A. Schneeweiss, S. Paepke, M. Untch, N. Burchardi, K. Mehta, S. Loibl for the German Breast Group and Austrian Breast and ColonCancer Study Group Investigators

Description
ISSN:	0959-8049

Similar Items